首页> 外文期刊>APMIS: Acta Pathologica, Microbiologica et Immunologica Scandinavica >Somatic frameshift mutations of bone morphogenic protein receptor 2 gene in gastric and colorectal cancers with microsatellite instability.
【24h】

Somatic frameshift mutations of bone morphogenic protein receptor 2 gene in gastric and colorectal cancers with microsatellite instability.

机译:具有微卫星不稳定性的胃癌和大肠癌中骨形态发生蛋白受体2基因的体细胞移码突变。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Mounting evidence exists that perturbation of bone morphogenic protein (BMP) signaling is involved in cancer development, especially in gastrointestinal cancers. However, somatic mutations of the genes encoding BMP and BMP receptors have not yet been discovered in human cancer tissues. By analyzing a public database, we found that BMP receptor 2 (BMPR2) and BMP1 genes had mononucleotide repeats in their coding sequences that could be mutation targets in cancers with microsatellite instability (MSI). In this study, we analyzed the mutation of BMPR2 and BMP1 genes in gastric (GC) and colorectal cancers (CRC) with MSI [31 GC with high MSI (MSI-H), 13 GC with low MSI (MSI-L), 38 CRC with MSI-H and 15 CRC with MSI-L] by single-strand conformation polymorphism analysis and DNA sequencing. Overall, we found seven frameshift mutations in the BMPR2 gene, but not in the BMP1 gene. The mutations were an identical deletion mutation of one base in the repeats (c.1748delA) that would result in premature stops of the amino acid synthesis (p.Asn583ThrfsX44). The BMPR2 mutations were detected in 6.5% of GC and 13.2% of CRC with MSI-H. All the cancers with the BMPR2 mutation showed loss of BMPR2 expression. Our data indicate that frameshift mutation of BMPR2 gene occurs in GC and CRC with MSI-H, and suggest that the BMPR2 mutation might contribute to cancer pathogenesis by inactivating BMPR2-mediated BMP signaling.
机译:越来越多的证据表明,骨形态发生蛋白(BMP)信号的扰动与癌症的发展有关,特别是在胃肠道癌症中。然而,尚未在人类癌症组织中发现编码BMP和BMP受体的基因的体细胞突变。通过分析公共数据库,我们发现BMP受体2(BMPR2)和BMP1基因在其编码序列中具有单核苷酸重复,这可能是微卫星不稳定性(MSI)癌症的突变靶标。在这项研究中,我们使用MSI分析了胃癌(GC)和大肠癌(CRC)中BMPR2和BMP1基因的突变[31 MSI高的GC(MSI-H),13 MSI低的GC(MSI-L),38通过单链构象多态性分析和DNA测序可检测出MSI-H的CRC和MSI-L的15 CRC]。总体而言,我们在BMPR2基因中发现了七个移码突变,但在BMP1基因中未发现。突变是重复序列中一个碱基的相同缺失突变(c.1748delA),这会导致氨基酸合成过早终止(p.Asn583ThrfsX44)。 MSI-H在6.5%的GC和13.2%的CRC中检测到BMPR2突变。所有具有BMPR2突变的癌症均显示BMPR2表达缺失。我们的数据表明BMPR2基因的移码突变发生在MS和MSI-H的GC和CRC中,并且表明BMPR2突变可能通过失活BMPR2介导的BMP信号传导来促进癌症的发病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号